Medicare Enrolled

Dr. Valerie Hadam, MD

Endocrinology · Mayfield Hts, OH
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
5850 LANDERBROOK DR STE 100, Mayfield Hts, OH 44124
4406462200
In practice since 2007 (18 years)
NPI: 1811187750 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Hadam from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hadam? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Hadam

Dr. Valerie Hadam is an endocrinology specialist in Mayfield Hts, OH, with 18 years of NPI registration. Based on federal Medicare data, Dr. Hadam performed 1,510 Medicare services across 711 unique beneficiaries.

Between the years covered by Open Payments, Dr. Hadam received a total of $15,109 from 73 pharmaceutical and/or device companies across 937 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Hadam is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 21% volume in OH $15,109 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,510
Medicare services
Top 21% in OH for endocrinology
711
Unique beneficiaries
$57
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~84 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
705 $87 $175
Denosumab injection (Prolia/Xgeva) 374 $0 $0
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
228 $56 $125
Hemoglobin A1c test (diabetes monitoring)
A blood test that measures your average blood sugar levels over the past two to three months.
93 $9 $40
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
89 $113 $270
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
21 $9 $52
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$15,109
Total received (2018-2024)
Avg $2,158/year across 7 years
Top 20% in OH for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
73
Companies
937
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,164 (87.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,945 (12.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,799
2023
$1,806
2022
$2,086
2021
$1,873
2020
$1,699
2019
$2,140
2018
$3,706

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$254
Novo Nordisk Inc
$223
Abbott Laboratories
$160
ABBVIE INC.
$146
Novartis Pharmaceuticals Corporation
$121
Boehringer Ingelheim Pharmaceuticals, Inc.
$96
Corcept Therapeutics
$79
Amgen Inc.
$69
Dexcom, Inc.
$63
VIVUS LLC
$59
Merck Sharp & Dohme LLC
$53
Neurocrine Biosciences, Inc.
$49
Antares Pharma, Inc.
$48
PFIZER INC.
$41
Astellas Pharma US Inc
$38
Verity Pharmaceuticals Inc.
$37
AIMMUNE THERAPEUTICS, INC.
$35
Medtronic, Inc.
$32
BETA BIONICS, INC.
$27
Averitas Pharma Inc.
$24
Xeris Pharmaceuticals, Inc.
$22
GlaxoSmithKline, LLC.
$20
Mannkind Corporation
$19
Chiesi USA, Inc.
$19
Acella Pharmaceuticals, LLC
$18
Ascendis Pharma Inc
$18
Phathom Pharmaceuticals, Inc.
$15
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$14
Top 3 companies account for 35.4% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$4,086
Lilly USA, LLC
$1,479
Amgen Inc.
$1,192
Abbott Laboratories
$957
Boehringer Ingelheim Pharmaceuticals, Inc.
$757
AstraZeneca Pharmaceuticals LP
$658
SANOFI-AVENTIS U.S. LLC
$523
ABBVIE INC.
$395
Janssen Pharmaceuticals, Inc
$296
PFIZER INC.
$241
Dexcom, Inc.
$237
Merck Sharp & Dohme Corporation
$228
AbbVie, Inc.
$215
Currax Pharmaceuticals LLC
$211
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$211
Insulet Corporation
$204
Xeris Pharmaceuticals, Inc.
$187
VIVUS, Inc.
$176
Shire North American Group Inc
$162
Corcept Therapeutics
$161
Antares Pharma, Inc.
$158
Novartis Pharmaceuticals Corporation
$134
Radius Health, Inc.
$131
VIVUS LLC
$127
Mannkind Corporation
$127
AbbVie Inc.
$123
Astellas Pharma US Inc
$120
IBSA Pharma Inc.
$113
Biohaven Pharmaceutical Holding Company Ltd.
$96
Bayer HealthCare Pharmaceuticals Inc.
$91
Merck Sharp & Dohme LLC
$82
Bayer Healthcare Pharmaceuticals Inc.
$82
Kowa Pharmaceuticals America, Inc.
$78
Medtronic, Inc.
$70
LifeScan, Inc.
$56
Alexion Pharmaceuticals, Inc.
$53
NESTLE HEALTHCARE NUTRITION INC.
$52
Neurocrine Biosciences, Inc.
$49
Acerus Pharmaceuticals Corporation
$43
Takeda Pharmaceuticals U.S.A., Inc.
$43
Amryt Pharma Holdings Ltd
$40
Verity Pharmaceuticals Inc.
$37
Gemini Laboratories, LLC
$36
AIMMUNE THERAPEUTICS, INC.
$35
GlaxoSmithKline, LLC.
$34
MannKind Corporation
$34
Amneal Pharmaceuticals LLC
$30
Sanofi Pasteur Inc.
$28
Horizon Therapeutics plc
$27
Ultragenyx Pharmaceutical Inc.
$27
BETA BIONICS, INC.
$27
Ironwood Pharmaceuticals, Inc
$24
Averitas Pharma Inc.
$24
Genentech USA, Inc.
$22
Chiesi USA, Inc.
$19
Acella Pharmaceuticals, LLC
$18
Ascendis Pharma Inc
$18
Medtronic Vascular, Inc.
$17
Eisai Inc.
$16
Aytu BioScience, Inc
$16
Dynavax Technologies Corporation
$16
Clarus Therapeutics Inc.
$16
Tandem Diabetes Care, Inc.
$15
Phathom Pharmaceuticals, Inc.
$15
Biohaven Pharmaceuticals, Inc.
$15
Exact Sciences Corporation
$14
Phadia US Inc.
$13
Amarin Pharma Inc.
$13
SANOFI PASTEUR INC.
$12
Nabriva Therapeutics, plc
$12
Valeritas, Inc.
$12
Medtronic MiniMed, Inc.
$11
E.R. Squibb & Sons, L.L.C.
$11
Top 3 companies account for 44.7% of all-time payments
Associated products mentioned in payments ›
ADACEL · AFREZZA · Aimovig · BAQSIMI · BASAGLAR · BREZTRI · BYDUREON · Belviq · CONTRAVE · CREON · CYCLOSET · ClosureFast · Cologuard Collection Kit · Creon · DUZALLO · Dexcom CGM · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · FARXIGA · FLUZONE HIGH-DOSE · FORTEO · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre Pro · FreeStyle Libre blood glucose Flash Monitoring System · GARDASIL · GARDASIL 9 · GVOKE HYPOPEN · GVOKE PFS · HUMULIN · HUMULIN R 500 · HUMULIN U · Heplisav-B · INVOKANA · ImmunoCAP · JANUVIA · JARDIANCE · JATENZO · Kerendia · Korlym · LEQVIO · LICART · LINZESS · LOKELMA · Livalo · MINIMED 770G · MINIMED 780G · MOUNJARO · MYALEPT · MYCAPSSA · Macrilen · Minimed 670G System · Myrbetriq · NATPARA (PARATHYROID HORMONE) · NOCDURNA · NP Thyroid 60 · NURTEC ODT · Natesto · OT Verio Flex Starter Kit · OT Verio Reflect "One Touch Meter and Strips" · Omnipod · OneTouch · Otezla · Otrexup · Ozempic · PAXLOVID · PNEUMOVAX 23 · PREVNAR 13 · PREVNAR 20 · PROCLAIM · Prolia · QSYMIA · QULIPTA · QUTENZA · RYBELSUS · Rybelsus · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SOMAVERT · STRENSIQ · SYNTHROID · Saxenda · Strensiq · Synthroid · TEPEZZA · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRULICITY · Tirosint · Tlando · Tresiba · Tymlos · UBRELVY · UNITHROID · V-GO · VARIVAX · VOQUEZNA · VRAYLAR · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XIFAXAN · XYOSTED · Xenleta · Xofluza · ZENPEP · iLet Bionic Pancreas · t:slim X2 insulin pump
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (87%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an endocrinology specialist in Mayfield Hts?
Compare endocrinologists in the Mayfield Hts area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists within 10 mi
45
Per 100K population
3.6
County median income
$62,823
Nearest hospital
HILLCREST HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Hadam is a clinical cardiology specialist, with above-average Medicare volume (top 21% in OH), with low-engagement industry engagement in the top 20% of OH peers, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Hadam experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Hadam performed 705 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hadam receive payments from pharmaceutical companies?
Yes. Dr. Hadam received a total of $15,109 from 73 companies across 937 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hadam's costs compare to other endocrinologists in Mayfield Hts?
Dr. Hadam's average Medicare payment per service is $57. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hadam) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →